BlackRock, Inc. 13D and 13G filings for Ocugen, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Ocugen, Inc. OCGN | BlackRock Inc. BLK | 5,522,302 1.900% | -13,092,456 (-70.33%) | Filing |
| 2024-11-08 2:17 pm Unchanged | 2024-09-30 | 13G | Ocugen, Inc. OCGN | BlackRock Inc. BLK | 18,614,758 6.500% | 0 (Unchanged) | Filing |
| 2024-10-22 6:06 pm Purchase | 2024-09-30 | 13G | Ocugen, Inc. OCGN | BlackRock Inc. BLK | 18,614,758 6.500% | 14,707,344 (+376.40%) | Filing |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Ocugen, Inc. OCGN | BlackRock Inc. BLK | 3,907,414 1.500% | -11,153,947 (-74.06%) | Filing |
| 2023-01-31 5:52 pm Purchase | 2022-12-31 | 13G | Ocugen, Inc. OCGN | BlackRock Inc. BLK | 15,061,361 6.900% | 2,130,230 (+16.47%) | Filing |
| 2022-02-04 4:26 pm Purchase | 2021-12-31 | 13G | Ocugen, Inc. OCGN | BlackRock Inc. BLK | 12,931,131 6.500% | 12,931,131 (New Position) | Filing |